📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-21 09:51
122 analysed today
FollowTelegram
122
Today
149,523
All-time analysed
42,890
Positive
6,652
Negative
91,308
Neutral
8,605
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
26 announcements match the current filters (relevance ≥ 5).
COLPAL Appoints Manish Anandani as MD & CEO for 5-Year Term; Prabha Narasimhan Resigns
Colgate-Palmolive (India) Limited has announced a leadership transition as Ms. Prabha Narasimhan resigns as MD and CEO effective close of business September 27, 2026, following her promotion to Executive Vice President - Marketing, Asia-Pacific Division at parent Colgate-Palmolive. To succeed her, the Board has approved the appointment of Mr. Manish Anandani as MD and CEO for a 5-year tenure effective September 28, 2026 to September 27, 2031, subject to shareholder approval. Mr. Anandani brings 30 years of FMCG industry experience, most recently serving as MD for India & South Asia at Kenvue, alongside previous senior stints at Colgate-Palmolive from 2005 to 2018.
Confidence: HIGH
What changedMs. Prabha Narasimhan will step down on September 27, 2026, and Mr. Manish Anandani has been appointed as MD & CEO for a 5-year term starting September 28, 2026.
Why it mattersEnsures planned succession and leadership continuity under an FMCG veteran with deep prior experience at Colgate and Kenvue to drive oral care growth and eCommerce expansion.
Term of appointment: 5 yearsAppointment effective date: September 28, 2026Cessation effective date: September 27, 2026Incoming MD & CEO experience: 30 years
📅 Short termBusiness operations are expected to continue smoothly with a clear 1-month handover timeline ahead of the September 2026 changeover.
📈 Long termAnandani's expertise in digital transformation and customer development will be pivotal in driving Colgate's premiumization and distribution strategy across modern and quick-commerce channels.
⚠ Risk flags
- Leadership transition execution risk
- Shareholder and statutory approval pending
Key Highlights
Ms. Prabha Narasimhan resigns as MD & CEO effective September 27, 2026, upon promotion to EVP Marketing (Asia-Pacific) at parent firm
Mr. Manish Anandani appointed as MD & CEO for a 5-year term from September 28, 2026, to September 27, 2031
Incoming CEO has 30 years of leadership experience across sales, marketing, and digital/eCommerce transformation
Appointment is subject to shareholder approval and requisite statutory clearances
👀 What to Watch
Track the formal shareholder approval process and monitor executive transition milestones leading up to the September 28, 2026 handover.
Colgate-Palmolive India Appoints Manish Anandani as MD & CEO for 5-Year Term
Colgate-Palmolive (India) Limited announced the appointment of Mr. Manish Anandani as Managing Director and CEO for a 5-year term from September 28, 2026 to September 27, 2031, subject to shareholder approval. He succeeds Ms. Prabha Narasimhan, who resigns effective September 27, 2026 following her promotion to Executive Vice President - Marketing, Asia-Pacific Division at the parent company. Mr. Anandani brings 30 years of FMCG experience, having previously served as MD for India & South Asia at Kenvue and working with Colgate-Palmolive from 2005 to 2018.
Confidence: HIGH
What changedMs. Prabha Narasimhan has resigned as MD & CEO effective September 27, 2026, and Mr. Manish Anandani has been appointed as her successor for 5 years starting September 28, 2026.
Why it mattersTop-level leadership changes in FMCG companies influence premiumization execution, distribution channel management, and market share defense against domestic and D2C oral care competitors.
Tenure of Appointment: 5 yearsEffective Start Date: September 28, 2026Outgoing CEO Cessation Date: September 27, 2026Experience of Incoming CEO: 30 years
📅 Short termOrderly leadership transition within the parent group network is unlikely to disrupt ongoing operations or quarterly performance.
📈 Long termThe new leadership's focus on digital transformation, eCommerce channels, and category growth will drive the company's long-term volume and margin trajectory.
⚠ Risk flags
- Execution risks during leadership handover
- Intense competitive pressure in mass oral care segments
Key Highlights
Manish Anandani appointed as MD & CEO for a 5-year tenure effective September 28, 2026
Current MD & CEO Prabha Narasimhan steps down effective September 27, 2026 on global promotion
Incoming CEO brings 30 years of industry experience across sales, marketing, and general management
Transition is subject to statutory and shareholder approvals
👀 What to Watch
Track shareholder voting on the appointment and watch for any strategic commentary or capital allocation shifts under the new leadership in upcoming earnings calls.
COLPAL Appoints Manish Anandani as MD & CEO for 5-Year Term; Prabha Narasimhan Resigns
Colgate-Palmolive (India) Limited has announced that Ms. Prabha Narasimhan has resigned as Managing Director and CEO effective close of business on September 27, 2026, following her promotion to Executive Vice President - Marketing, Asia-Pacific Division of the parent company. The Board has approved the appointment of Mr. Manish Anandani as the new MD and CEO for a 5-year term from September 28, 2026, to September 27, 2031, subject to shareholder approval. Mr. Anandani brings 30 years of FMCG experience, having previously served as MD for India & South Asia at Kenvue and working at Colgate-Palmolive from 2005 to 2018.
Confidence: HIGH
What changedPrabha Narasimhan is stepping down as MD & CEO to take an Asia-Pacific role at the parent company, replaced by Manish Anandani on a 5-year term.
Why it mattersEnsures leadership continuity with an industry veteran who has prior institutional experience at Colgate-Palmolive, maintaining focus on premiumization and category growth.
Incoming CEO Term: 5 years (Sep 28, 2026 to Sep 27, 2031)Incoming CEO Experience: 30 yearsOutgoing CEO Cessation Date: September 27, 2026
📅 Short termOrderly transition planned well in advance; minimal near-term operational disruption expected.
📈 Long termMr. Anandani's background in eCommerce transformation and digital retail execution at Kenvue and Colgate will guide long-term volume and market share strategies.
⚠ Risk flags
- Execution continuity during top management transition in a competitive oral care segment
Key Highlights
Ms. Prabha Narasimhan steps down as MD & CEO effective close of business on September 27, 2026, on promotion to APAC leadership
Mr. Manish Anandani appointed as MD & CEO for a 5-year consecutive term effective September 28, 2026, to September 27, 2031
Incoming CEO brings 30 years of industry experience across sales, marketing, and leadership, including previous 13-year tenure at Colgate (2005-2018)
Appointment is subject to the approval of shareholders and applicable statutory clearances
👀 What to Watch
Track the upcoming shareholder voting on the appointment and monitor the smooth handover of leadership ahead of the September 28, 2026 effective date.
Colgate-Palmolive Appoints Manish Anandani as MD & CEO for 5 Years as Prabha Narasimhan Steps Down
Colgate-Palmolive (India) Limited has announced the appointment of Mr. Manish Anandani as Managing Director and CEO for a 5-year term effective September 28, 2026, to September 27, 2031. He succeeds Ms. Prabha Narasimhan, who resigns effective September 27, 2026, following her promotion to Executive Vice President - Marketing, Asia-Pacific Division at the parent company. Mr. Anandani brings 30 years of FMCG experience, including serving as MD for India & South Asia at Kenvue and an earlier 13-year stint at Colgate-Palmolive. The appointment is subject to shareholder approval.
Confidence: HIGH
What changedLeadership transition at the top executive level, with Manish Anandani taking over from Prabha Narasimhan as MD & CEO from September 28, 2026.
Why it mattersA planned CEO transition at India's oral care market leader determines the execution of key growth pillars, including premiumization, digital transformation, and addressing mass-market competitive intensity.
Appointment tenure: 5 yearsEffective appointment date: September 28, 2026Incumbent cessation date: September 27, 2026Incoming CEO industry experience: 30 years
📅 Short termOrderly transition expected over the roughly one-month handover period ending September 27, 2026, with minimal near-term operational disruption.
📈 Long termMr. Anandani's background in customer development, digital/eCommerce transformation, and consumer health will be pivotal in steering COLPAL's channel mix and product innovation.
⚠ Risk flags
- Execution and strategy continuity risks standard to top management changes.
- Pending approval from company shareholders.
Key Highlights
Mr. Manish Anandani appointed as MD & CEO for a 5-year term from September 28, 2026, to September 27, 2031.
Incumbent MD & CEO Ms. Prabha Narasimhan resigns effective September 27, 2026, on promotion to EVP - Marketing, Asia-Pacific Division.
Incoming CEO brings 30 years of FMCG experience, having previously worked at Colgate-Palmolive (2005–2018) and Kenvue.
👀 What to Watch
Track upcoming shareholder voting on the appointment and watch for any strategic commentary from the new leadership regarding volume growth, pricing, and eCommerce channel strategy in subsequent quarterly calls.
COLPAL Investor Day 2026: Q1 Net Sales Up 12% YoY to ₹1,591 Cr, NPAT Rises 10.6% to ₹343 Cr
Colgate-Palmolive (India) Limited released its Investor Day 2026 presentation detailing strategic growth drivers and financial performance. Net sales for Q1 FY27 grew 12.0% YoY to ₹1,591 Crore, while Jan-Jun 2026 net sales rose 10.5% YoY. Net Profit after Tax (NPAT) for Q1 reached ₹343 Crore (up 10.6% YoY) with an NPAT margin of 22.3%. Strategic execution is focused on driving consumption frequency, expanding premium mix, and scaling retail direct reach to 1.7 million stores (7.1 million total reach).
Confidence: HIGH
What changedCOLPAL presented an updated strategic roadmap at its Investor Day 2026, detailing category expansion, premiumization progress, and Q1 FY27 financial results.
Why it mattersDemonstrates accelerating topline growth (12% YoY in Q1) led by premium innovations, dentist-led therapeutics, and modern trade expansion while sustaining ~22% net margins.
Q1 FY27 Net Sales: ₹ 1,591 CroreQ1 FY27 Net Sales Growth (YoY): 12.0%Q1 FY27 NPAT: ₹ 343 CroreQ1 FY27 NPAT Margin: 22.3%Direct Store Reach: 1.7 Mn storesTotal Store Reach: 7.1 Mn stores
📅 Short termThe strategic presentation provides clarity on healthy double-digit volume/value acceleration in early FY27, supporting near-term sentiment.
📈 Long termLong-term compounding is anchored on per-capita oral care habit development (brushing twice daily), therapeutics expansion (Periogard), and premium category upgrades.
⚠ Risk flags
- Shift toward quick commerce requiring higher channel investments
- Competitive intensity in the core mass toothpaste segment
- Rural consumption growth pacing
Key Highlights
Q1 FY27 Net Sales grew 12.0% YoY to ₹1,591 Crore, following +9% in Jan-Mar 2026 and +12% in Apr-Jun 2026.
Q1 FY27 NPAT rose 10.6% YoY to ₹343 Crore with an NPAT margin of 22.3% of Net Sales.
Direct store coverage stands at 1.7 million stores out of a total reach of 7.1 million stores.
Modern Trade and E-commerce channel contribution expanded to 20% YTD 2026, with Quick Commerce making up ~40% of digital.
E-commerce business delivers ~400 bps higher market share and ~400 bps higher margins with over 50% premium mix.
👀 What to Watch
Monitor whether double-digit topline momentum persists across coming quarters and assess gross margin impact from the shifting channel mix toward Quick Commerce.
COLPAL Q1 FY27: 12% Net Sales Growth to ₹1,590.6 Cr; Net Profit Rises to ₹343.1 Cr
Colgate-Palmolive (India) reported a robust 12% YoY growth in Net Sales for Q1 FY27, reaching ₹1,590.6 Cr. Net Profit for the quarter stood at ₹343.1 Cr, reflecting an 11% growth when excluding one-off and exceptional items. The company continues to focus on premiumization and digital agility, with its Baddi plant transitioning 75% of shop-floor processes to paperless systems via AI. For the full year FY26, the company maintained a strong payout with total dividends of ₹48 per share.
Confidence: HIGH
What changedCOLPAL reported its Q1 FY27 results showing accelerated topline growth (12%) compared to the 9% domestic growth seen in Q4 FY26.
Why it mattersThe results demonstrate COLPAL's ability to drive double-digit growth in a competitive FMCG environment while maintaining high capital efficiency (ROCE of 121% in FY25).
Q1 FY27 Net Sales: ₹1,590.6 CrQ1 FY27 Net Profit: ₹343.1 CrYoY Sales Growth: 12%FY26 Total Dividend: ₹48 per shareDomestic Sourcing %: 92.7%Renewable Electricity Usage: 60%
📅 Short termThe stock is likely to react positively to the double-digit topline growth and steady profit margins reported for the first quarter.
📈 Long termCOLPAL's structural shift toward AI-led manufacturing and premiumization supports its long-term moat and high dividend-paying capacity.
⚠ Risk flags
- High competitive intensity in the mass toothpaste segment
- Potential channel conflicts between General Trade and Quick Commerce
Key Highlights
Net Sales for Q1 FY27 grew 12% YoY to ₹1,590.6 Cr compared to ₹1,420.6 Cr in Q1 FY26.
Net Profit (adjusted for one-offs) increased by 11% YoY, with reported PAT at ₹343.1 Cr.
Total dividend payout for FY26 confirmed at ₹48 per share (two interims of ₹24 each).
Domestic sourcing reached 92.7% of total goods in FY26, supporting the 'Make in India' initiative.
Operational efficiency improved with carbon emissions reduced by 43% against the baseline.
👀 What to Watch
Monitor the sustainability of double-digit topline growth and the success of premium launches like Visible White Purple in driving margins. Watch for further updates on volume growth in the mass segment (Colgate Strong Teeth) to gauge market share stability.
COLPAL Reports 12% Q1 Topline Growth and Confirms Rs 48 Total Dividend for FY26
At its 85th AGM, Colgate-Palmolive (India) reported a robust 12% YoY topline growth for Q1 FY27, with sales reaching Rs 1,591 crore. The company confirmed a total dividend of Rs 48 per share for FY26, representing a yield of approximately 2.2% at current prices. Management highlighted a 9% growth in domestic net sales for Q4 FY26 and a 10% increase in advertising spend to defend market share. Significant ESG progress was noted, including a 43% reduction in carbon emissions and 100% transition to recyclable toothpaste tubes.
Confidence: HIGH
What changedThe company transitioned into the new fiscal year (FY27) with double-digit growth and formalized its FY26 shareholder payouts while reporting significant operational efficiency gains through AI and automation.
Why it mattersThe 12% growth indicates strong brand resilience and successful premiumization in a competitive FMCG environment, supporting the company's high ROCE profile (121% in FY25).
Q1 FY27 Sales: Rs 1,591 croreQ1 FY27 Net Profit: Rs 343 croreTotal FY26 Dividend: Rs 48 per shareDividend Yield: ~2.2%Carbon Emission Reduction: 43%
📅 Short termThe stock may see positive sentiment driven by the 12% topline growth and the confirmation of healthy dividend payouts.
📈 Long termCOLPAL's focus on 'science-backed innovation' and digital manufacturing (75% paperless shop floors) positions it to maintain its dominant market leadership and high capital efficiency.
⚠ Risk flags
- High competitive intensity in the mass segment
- Potential channel conflicts between General Trade and Quick Commerce
- Softening urban demand could impact volume growth
Key Highlights
Q1 FY27 Sales reached Rs 1,591 crore, a 12% increase from Rs 1,421 crore YoY
Total dividend for FY26 confirmed at Rs 48 per share (two interims of Rs 24 each)
Net profit for Q1 FY27 stood at Rs 343 crore, up from Rs 321 crore YoY
Advertising investments increased by 10% to drive brand health and household penetration
Achieved 92.7% local sourcing of goods within India for FY 2025-26
👀 What to Watch
Watch for the sustainability of the 12% volume-led growth in upcoming quarters and the impact of increased advertising spend on operating margins amidst high competitive intensity.
12% Revenue Growth in Q1 FY27; Gross Margins Expand to 69.7%
Colgate-Palmolive (India) reported a robust 12% YoY increase in revenue to ‡1,591 crore for Q1 FY27, driven by high-single-digit volume growth in its toothpaste portfolio. Net profit rose 7% to ‡343 crore, though adjusted for one-off items, the growth was 11% YoY. Gross margins expanded by 110 bps to 69.7%, which the company aggressively reinvested into brand building, with advertising spend jumping 33.7% YoY to ‡252 crore. The company maintains an exceptionally high ROCE (108% TTM) and remains debt-free with only ‡47 crore in total debt.
Confidence: HIGH
What changedCOLPAL has shifted from muted growth to double-digit topline growth, supported by volume expansion and a significant increase in brand reinvestment.
Why it mattersThe results indicate that COLPAL's premiumization strategy and 'Funding the Growth' cost-saving initiatives are successfully offsetting commodity volatility while driving volume in a mature market.
Revenue (Q1 FY27): ‡1,590.56 crNet Profit (Q1 FY27): ‡343.08 crGross Margin: 69.7%Ad Spend as % of Revenue: 15.8%EPS (Q1 FY27): ‡12.61
📅 Short termThe stock may see positive sentiment due to the strong 12% topline growth and healthy volume recovery, which exceeds recent historical trends.
📈 Long termCOLPAL's focus on premiumization and science-backed innovation (e.g., Visible White, Colgate Total) supports its high-margin profile and dominant market leadership.
⚠ Risk flags
- Commodity price volatility due to geopolitical uncertainties
- High competitive intensity in the mass-market segment
- Potential channel conflicts between General Trade and Quick Commerce
Key Highlights
Revenue from operations increased 12% YoY to ‡1,590.56 crore.
Gross margin reached 69.7%, representing a year-on-year increase of 110 bps.
Advertising expenses rose significantly by 33.7% to ‡251.86 crore to support brand building.
Toothpaste portfolio achieved high-single-digit volume growth, led by premium segments.
Net profit after tax stood at ‡343.08 crore, up from ‡320.62 crore in the previous year's quarter.
👀 What to Watch
Watch for the sustainability of high-single-digit volume growth in upcoming quarters and the impact of increased advertising spend on market share in the premium toothpaste segment.
12% Revenue Growth in Q1 FY27; Gross Margins Expand to 69.7%
Colgate-Palmolive (India) reported a robust 12% YoY increase in net sales to ₹1,591 crore for Q1 FY27, driven by high-single-digit volume growth in its toothpaste portfolio. Net profit grew 7% YoY to ₹343 crore, though adjusted for one-off exceptional items, the growth was 11%. The company successfully expanded its gross margin by 110 bps to 69.7%, which was partially reinvested into brand building, as evidenced by a 33.7% surge in advertising expenditure to ₹251.86 crore.
Confidence: HIGH
What changedThe company has transitioned from muted growth to double-digit topline growth (12%) with a specific focus on volume-led expansion and premiumization.
Why it mattersAs the market leader in Oral Care, COLPAL's ability to drive volume growth while expanding gross margins indicates strong brand equity and pricing power despite high competitive intensity in the FMCG sector.
Revenue from Operations (Q1): ₹1,590.56 crNet Profit (Q1): ₹343.08 crGross Margin: 69.7%Advertising Expense: ₹251.86 crEPS (Basic): ₹12.61
📅 Short termThe stock may react positively to the double-digit sales growth and volume recovery, which outperforms recent trends in the broader FMCG sector.
📈 Long termThe company's focus on 'Funding the Growth' initiatives and premiumization (e.g., Visible White, Total) supports its high ROCE profile (108%+) and long-term compounding potential.
⚠ Risk flags
- High advertising intensity required to maintain market share
- Commodity price volatility impacting future margins
- Geopolitical uncertainties
Key Highlights
Net Sales increased 12% YoY to ₹1,590.56 crore from ₹1,420.64 crore.
Gross Margin reached 69.7%, representing a year-on-year increase of 110 bps.
Advertising spend rose significantly by 33.7% to ₹251.86 crore, representing 15.8% of sales.
Toothpaste portfolio achieved high-single-digit volume growth, led by premium segments.
Exceptional item of ₹3.34 crore recorded for severance and organizational restructuring.
👀 What to Watch
Watch for the sustainability of volume growth in the upcoming quarters to see if the aggressive 33.7% increase in advertising spend continues to yield market share gains and if premiumization can offset commodity price volatility.
12% Revenue Growth for COLPAL in Q1 FY27; Net Profit Rises to ₹343 Cr
Colgate-Palmolive (India) reported a strong Q1 FY27 with net sales growing 12% YoY to ₹1,591 Cr, driven by high-single-digit volume growth in toothpaste. Reported net profit increased 7% YoY to ₹343 Cr, while adjusted profit (excluding one-offs) grew by 11%. The company achieved a robust gross margin of 69.7%, up 110 bps, which it utilized to aggressively increase advertising spend by 33.7% to ₹251.9 Cr. Premiumization remains a key driver, with stellar performance noted in the premium toothpaste segment.
Confidence: HIGH
What changedCOLPAL transitioned from muted growth to double-digit revenue growth (12%) and high-single-digit volume growth in Q1 FY27.
Why it mattersThe results demonstrate COLPAL's ability to drive volume growth through premiumization and reinvest efficiency-led margin gains into brand equity, maintaining its 100%+ ROCE profile.
Revenue from Operations: ₹1,590.56 CrNet Profit: ₹343.08 CrGross Margin: 69.7%Ad Spend as % of Sales: 15.8%YoY Sales Growth: 12.0%
📅 Short termThe stock is likely to react positively to the double-digit topline growth and volume recovery, which outperforms recent historical trends.
📈 Long termThe focus on premiumization (Visible White, Total) and digital agility suggests a structural shift toward higher-value products, supporting long-term margin stability.
⚠ Risk flags
- High competitive intensity in the mass segment
- Volatility in commodity prices impacting gross margins
- Potential channel conflicts with emerging Quick Commerce
Key Highlights
Net Sales increased 12.0% YoY to ₹1,590.56 Cr for the quarter ended June 30, 2026.
Gross margins expanded by 110 bps YoY to reach 69.7%.
Advertising expenditure surged 33.7% YoY to ₹251.86 Cr to support brand building.
Toothpaste portfolio achieved high-single-digit volume growth, led by premium segments.
Net Profit after tax stood at ₹343.08 Cr, representing a 7% reported YoY increase.
👀 What to Watch
Investors should monitor if the high-single-digit volume growth can be sustained in subsequent quarters and whether the aggressive 33.7% increase in ad spending successfully defends market share against competitors.
Colgate-Palmolive India Declares Rs 24 Interim Dividend; Re-appoints CFO for 5 Years
Colgate-Palmolive (India) Limited has declared a second interim dividend of Rs 24 per equity share for the financial year 2025-26. The board has set June 1, 2026, as the record date for this dividend, with payments commencing on June 17, 2026. Alongside the financial results, the company approved the re-appointment of Mr. Jacob Sebastian Madukkakuzy as CFO and Whole-time Director for a five-year term starting October 2026. The company also confirmed it remains debt-free in terms of the 'Large Corporate' framework, with no outstanding long-term borrowings exceeding Rs 1,000 crores.
Key Highlights
Declared a second interim dividend of Rs 24 per equity share of Re 1 face value
Set June 1, 2026, as the record date for dividend eligibility with payment by June 17, 2026
Re-appointed Mr. Jacob Sebastian Madukkakuzy as CFO for a 5-year term until October 2027
Auditors issued an unmodified opinion on the audited financial results for FY ended March 31, 2026
Confirmed non-applicability of 'Large Corporate' framework with borrowings below Rs 1,000 crores
👀 What to Watch
Investors should ensure they hold shares by the June 1 record date to qualify for the Rs 24 dividend. The re-appointment of the CFO ensures management stability and continuity in financial leadership.
Colgate-Palmolive India Q4 FY26: Domestic Sales Up 9.2%, EBITDA Margin Exceeds 32%
Colgate-Palmolive (India) reported a strong Q4 FY26 with domestic sales growth of 9.2% and net sales of Rs. 1,583 crores. The company maintained best-in-class EBITDA margins at over 32% and gross margins at 69.6%, despite increasing brand investments by 10% to approximately Rs. 200 crores. While the full-year top-line growth remained flat, the second half of the year showed a recovery with over 5% growth. Management noted a narrowing gap between rural and urban growth and is focusing heavily on premiumization and oral health education.
Key Highlights
Q4 domestic net sales grew 9.2% YoY to Rs. 1,583 crores, showing broad-based growth across core and premium segments.
Maintained superior EBITDA margins at over 32% and gross margins at 69.6% for the quarter.
Brand investments increased by 10% YoY to nearly Rs. 200 crores to drive consumption and premiumization.
New 'Colgate Strong Teeth' formulation is clinically proven to be 8.5x more effective at re-mineralizing enamel.
Urban markets are showing signs of recovery while rural growth is beginning to converge with urban levels.
👀 What to Watch
Investors should find confidence in the company's resilient margin profile and the recovery in top-line growth during the second half of the fiscal year. The strategic focus on premiumization and increased advertising spend positions the company well for value-led growth.
Colgate-Palmolive India Q4 Domestic Growth Hits 9.2% with 32% EBITDA Margin
Colgate-Palmolive (India) reported a strong Q4 FY26 with net sales of ‑1,583 crores, representing a 9% YoY growth driven by a 9.2% increase in domestic sales. While the full-year performance remained flat, the company saw a significant recovery in the second half with 5% growth compared to the first half. EBITDA margins remained industry-leading at over 32%, supported by a high gross margin of 69.6%. The management is aggressively investing in brand building, with a 10% increase in advertising spend this quarter to ‑200 crores, focusing on premiumization and core portfolio strength.
Key Highlights
Q4 Net Sales reached ‑1,583 crores with domestic growth accelerating to 9.2% YoY.
Maintained best-in-class EBITDA margins at 32% and gross margins at 69.6%.
Brand investments increased by 10% YoY to approximately ‑200 crores in Q4.
Clinical tests show Colgate Strong Teeth is 8.5x more effective at re-mineralization than competitors.
The 'Bright Smiles, Bright Future' program reached 1 crore children across 35,000 schools in 2025.
👀 What to Watch
Investors should take confidence in the H2 recovery and the company's ability to maintain 32% EBITDA margins despite increased ad spending. The stock remains a strong core portfolio pick for those seeking stable FMCG returns with a focus on premiumization.
Colgate-Palmolive India Q4 Domestic Sales Up 9.2%; EBITDA Margins Robust at 32%
Colgate-Palmolive (India) reported a strong Q4 FY26 with net sales of ₹1,583 crores, representing a 9% YoY growth, driven by a 9.2% increase in domestic sales. While the full-year performance remained flat due to earlier headwinds, the second half of the year showed recovery with over 5% growth. The company maintained superior profitability with gross margins at 69.6% and EBITDA margins exceeding 32%. Management is aggressively investing in brand building, increasing advertising spend by 10% to approximately ₹200 crores in Q4.
Key Highlights
Q4 Net Sales reached ₹1,583 crores, a 9% YoY increase, with domestic growth at 9.2%.
Maintained best-in-class EBITDA margins at 32% and gross margins at 69.6%.
Brand investments stepped up by 10% YoY to nearly ₹200 crores in the final quarter.
The 'Bright Smiles, Bright Future' program reached 1 crore children across 35,000 schools in 2025.
Free dental checkup initiative expanded to 500 million packs with 1 million redemptions already recorded.
👀 What to Watch
Investors should take note of the accelerating domestic growth and resilient margin profile as signs of a turnaround. The focus on premiumization and increased ad-spend suggests a strategy to capture higher-value segments in a recovering urban market.
Colgate Q4 Net Sales Up 9% to ₹1,583 Cr; Declares ₹24/Share Second Interim Dividend
Colgate-Palmolive India reported a 9% YoY growth in Q4 FY26 net sales to ₹1,583 crore, driven by a 9.2% growth in the domestic business. While reported net profit for the quarter was flat at ₹353 crore, adjusted net profit (excluding one-offs) grew by 9% YoY. The company declared a second interim dividend of ₹24 per share, bringing the total dividend for FY26 to ₹48 per share. A key positive is the premium portfolio, which is currently growing at three times the overall company growth rate.
Key Highlights
Q4 FY26 Net Sales increased 9% YoY to ₹1,583 crore from ₹1,452 crore.
Adjusted Net Profit grew 9% YoY, though reported PAT was ₹353 crore vs ₹355 crore in the base year.
Declared a second interim dividend of ₹24 per share with a record date of June 1, 2026.
Premium segment growth outperformed the overall company average by 3x.
Full-year FY26 total dividend stands at ₹48 per share on a face value of ₹1.
👀 What to Watch
The rebound in sales growth and strong performance in the premium segment are positive indicators for long-term margin expansion. Investors can continue to hold for steady growth and attractive dividend yields.
COLPAL Q4 Net Sales Up 9% to ₹1,583 Cr; Declares ₹24/share Interim Dividend
Colgate-Palmolive India reported a 9% YoY growth in Q4 FY26 net sales to ₹1,583 crore, driven by a 9.2% growth in the domestic business. The company declared a second interim dividend of ₹24 per share, bringing the total FY26 dividend to ₹48 per share. While reported net profit for the quarter was slightly lower at ₹353 crore due to one-off items, adjusted profit grew by 9%. The premium segment significantly outperformed, growing at three times the company's overall rate, signaling successful premiumization.
Key Highlights
Q4 FY26 Net Sales grew 9% YoY to ₹1,583 crore, with domestic growth at 9.2%.
Declared a second interim dividend of ₹24 per share; total FY26 dividend stands at ₹48 per share.
Adjusted Net Profit for Q4 grew 9% YoY, though reported PAT was ₹353 crore due to one-offs.
Premium portfolio growth was 3x the overall company growth rate in Q4 FY26.
CFO Jacob Sebastian Madukkakuzy re-appointed for a 5-year term starting October 2026.
👀 What to Watch
Investors should take note of the strong Q4 recovery and the success of the premiumization strategy which is driving higher growth. The consistent high dividend payout of ₹48 for the full year remains a key positive for long-term yield-seeking investors.
Colgate-Palmolive Q4 Net Sales Up 9% to ₹1,583 Cr; Declares ₹24/Share Interim Dividend
Colgate-Palmolive India reported a 9% YoY growth in Q4 FY26 net sales, reaching ₹1,583 crore, driven by a strong rebound in both volume and pricing. While reported net profit for the quarter was slightly lower at ₹353 crore due to one-off items, adjusted profit grew by 9% YoY. The company declared a second interim dividend of ₹24 per share, bringing the total FY26 payout to ₹48 per share. Management highlighted that the premium segment is growing at three times the overall company rate, supported by a 10% increase in advertising spend.
Key Highlights
Q4 FY26 Net Sales grew 9% YoY to ₹1,583 crore, showing a strong rebound in domestic business momentum.
Adjusted Net Profit for Q4 grew 9% YoY, although reported PAT was ₹353 crore compared to ₹355 crore in the previous year.
Declared a second interim dividend of ₹24 per share, resulting in a total dividend of ₹48 per share for FY26.
Premium portfolio growth outperformed the company average by 3x, fueled by a 10% increase in advertising expenditure.
Re-appointed Mr. Jacob Sebastian Madukkakuzy as CFO for a further 5-year term starting October 2026.
👀 What to Watch
Investors should take confidence in the accelerating topline growth and the success of the premiumization strategy which is driving higher margins. The stock remains a solid choice for dividend-seeking investors given the ₹48 total payout for the fiscal year.
Colgate-Palmolive Q4 Net Sales Up 9% to ₹1,583 Cr; Declares ₹24/Share Interim Dividend
Colgate-Palmolive India reported a 9% YoY growth in Q4 FY26 net sales, reaching ₹1,583 crore, driven by a strong rebound in domestic business. While reported net profit for the quarter was slightly lower at ₹353 crore, adjusted profit grew by 9% after excluding one-off items. The company declared a second interim dividend of ₹24 per share, bringing the total FY26 payout to ₹48 per share. Management highlighted that the premium segment is growing at 3x the company average, indicating successful premiumization efforts.
Key Highlights
Q4 FY26 Net Sales increased 9% YoY to ₹1,583 crore from ₹1,452 crore.
Declared a second interim dividend of ₹24 per share with a record date of June 1, 2026.
Premium portfolio growth outperformed the overall company growth by 3x in Q4.
Full-year FY26 Net Profit stood at ₹1,325 crore, impacted by inverted duty structure charges and GST changes.
Re-appointed Jacob Sebastian Madukkakuzy as CFO for a 5-year term starting October 2026.
👀 What to Watch
Investors should take note of the strong Q4 recovery and the healthy dividend yield. The company's focus on premiumization and volume-led growth makes it a solid hold for long-term portfolios.
Colgate-Palmolive Q4 Net Sales Up 9% to ₹1,583 Cr; Declares ₹24/Share Interim Dividend
Colgate-Palmolive (India) reported a 9% YoY growth in Q4 FY26 net sales to ₹1,583 crore, driven by broad-based performance across core and premium portfolios. The company declared a second interim dividend of ₹24 per share, bringing the total dividend for FY26 to ₹48 per share. While full-year net profit saw a decline to ₹1,325 crore due to one-off tax and GST-related charges, the adjusted Q4 profit grew by 9%. The board also approved the re-appointment of Jacob Sebastian Madukkakuzy as CFO for a five-year term.
Key Highlights
Q4 FY26 net sales grew 9% YoY to ₹1,583 crore, with domestic business growing at 9.2%.
Declared a second interim dividend of ₹24 per share; total FY26 dividend stands at ₹48 per share.
Premium segment growth was 3x the overall company growth rate in Q4.
Full-year FY26 net profit stood at ₹1,325 crore, impacted by GST-related inverted duty structure charges.
CFO Jacob Sebastian Madukkakuzy re-appointed for a 5-year term starting October 2026.
👀 What to Watch
Investors should focus on the strong recovery in sales growth and the company's successful premiumization strategy. The high dividend yield remains attractive for long-term income-seeking investors.
COLPAL Q4 Net Sales Up 9%, Declares ₹24 Dividend, Re-appoints CFO for 5 Years
Colgate-Palmolive (India) reported a 9% YoY growth in Q4 FY26 net sales to ₹1,583 crore, driven by a 9.2% growth in the domestic business. The company successfully executed its premiumization strategy, with the premium segment growing 3x faster than the overall company average. A second interim dividend of ₹24 per share was declared, bringing the total FY26 payout to ₹48 per share. Additionally, the board approved the re-appointment of Mr. Jacob Sebastian Madukkakuzy as CFO for a five-year term starting October 2026, ensuring leadership continuity.
Key Highlights
Q4 FY26 Net Sales rose 9% YoY to ₹1,583 crore from ₹1,452 crore.
Second interim dividend of ₹24 per share declared; total FY26 dividend at ₹48 per share.
Premium portfolio growth outperformed the company average by 3x during the quarter.
CFO Jacob Sebastian Madukkakuzy re-appointed for a 5-year term until October 2031.
FY26 full-year Net Profit stood at ₹1,325 crore, impacted by one-off GST-related charges.
👀 What to Watch
Investors should find confidence in the rebounding 9% sales growth and the success of the premiumization strategy. The stock remains a strong defensive pick with a healthy dividend yield of ₹48 for the fiscal year.
